NCT00879164

Stellate Ganglion Nerve Block in Treating Women With Hot Flashes

Pilot Evaluation of a Stellate Ganglion Block for the Treatment of Hot Flashes

• Status: Completed
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

RATIONALE: A stellate ganglion nerve block may help relieve hot flashes in women. PURPOSE: This clinical trial is studying how well a stellate ganglion nerve block works in treating women with hot flashes.

Detailed description

OBJECTIVES: * To evaluate the impact of stellate ganglion blockade on hot flash scores. * To evaluate the toxicity of stellate ganglion blockade. OUTLINE: Patients undergo fluoroscopic-guided stellate ganglion blockade using bupivacaine hydrochloride in week 1. Patients complete a hot flash diary daily and a symptom experience diary weekly in weeks 1-7 and the Profile of Mood States questionnaire in weeks 1 and 7. After completion of study treatment, patients are followed at 2 months and then monthly for 1 year.

Conditions

• Hot Flashes

Interventions

Type	Name	Description
DRUG	bupivacaine hydrochloride
OTHER	questionnaire administration

Timeline

• Start date: 2009-04-01
• Primary completion: 2010-12-01
• Completion: 2010-12-01
• First posted: 2009-04-09
• Last updated: 2014-10-17

Locations

1 site across 1 country: United States